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Background: Chlamydia infections are notified at much higher rates in Aboriginal and/or Torres Strait Islander
people compared to non-Indigenous people. The Australian Collaboration Chlamydia Enhanced Sentinel
Surveillance System (ACCESS) was established to complement population-based surveillance.
Methods: We describe patient demographics, completeness of recording of Aboriginal and/or Torres Strait Islander
(‘Aboriginal’) status, chlamydia testing rates and positivity rates from the Aboriginal Community Controlled Health
Service (ACCHSs), General Practice (GP) clinics and Sexual Health Services (SHSs) networks in ACCESS during 2009.
Data were extracted from electronic medical records of each participating health service for consultations with
patients aged 16–29 years and for chlamydia testing and positivity.
Results: Data were included from 16–29 year olds attending six ACCHSs (n = 4,950); 22 SHSs (n = 20,691) and 25 GP
clinics (n = 34,462). Aboriginal status was unknown for 79.3% of patients attending GP clinics, 4.5% attending SHSs
and 3.8% of patients attending ACCHSs. Chlamydia testing rates among Aboriginal patients were 19.8% (95%
CI:18.6%-21.0%) at ACCHSs, 75.5% (95% CI:72.5%-78.4%) at SHSs and 4.3% (95% CI: 2.6%-6.6%) at GP clinics. Positivity
rates were highest in Aboriginal patients tested at SHSs at 22.7% (95% CI:19.5%-26.2%), followed by 15.8% (95%
CI:3.8%-43.4%) at GP clinics and 8.6% at ACCHSs (95% CI:7.9%-12.4%). This compared with non-Indigenous patients
positivity rates at SHSs of 12.7% (95% CI:12.2-13.2%); 8.6% (7.2%-11.3%) at GP clinics and 11.3% at ACCHSs (95%
CI:15.4%-24.9%).
Conclusions: Higher chlamydia positivity in Aboriginal people across a range of clinical services is reflected in
national notification data. Targeted efforts are required to improve testing rates in primary care services; to improve
identification of Aboriginal patients in mainstream services such as GP clinics; and to better engage with young
Aboriginal Australians.
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Chlamydia trachomatis is a sexually transmitted infection
that is easily diagnosed and treated, but most infections go
undetected since up to 80% are asymptomatic [1,2]. If left
untreated chlamydia can cause pelvic inflammatory dis-
ease which in turn can lead to tubal factor infertility and
ectopic pregnancy [3,4]. Chlamydia is the most commonly
notified infection in Australia with more than 80,000 cases
reported in 2013, a three-fold increase in the last decade
[5]. The burden of chlamydia is highest among young
Aboriginal and/or Torres Strait Islander people (hereafter
‘Aboriginal’) [6-8]. Notification rates among Aboriginal
people are 24 times higher than among non-Indigenous
people [9]; however, notification rates are subject to test-
ing biases [10,11].
The focus of the Council of Australian Government’s
commitment to Closing the Gap in health difference and
life expectancy between non-Indigenous and Aboriginal
peoples is principally directed towards mortality reduction
from chronic disease and improvements to child and ma-
ternal health [12], with little focus on sexually transmissible
infections (STIs) despite these causing substantial ill health
among Aboriginal people. However, included within the
Closing the Gap initiative are measures to improve surveil-
lance systems that lead to increased understanding of
disease among Aboriginal people and communities.
In this paper we report patient demographics, complete-
ness of recording of patients’ Aboriginal status, chlamydia
testing and positivity rates during 2009, within three
ACCESS clinical networks providing primary care: sexual
health services (SHSs), general practice (GP) clinics and
Aboriginal Community Controlled Health Services (ACC
HSs).Methods
Study design
The Australian Collaboration for Chlamydia Enhanced
Sentinel Surveillance System (ACCESS) program is an in-
dependent initiative that aims to complement and improve
interpretation of passive chlamydia surveillance data
among priority populations including Aboriginal people
[13]. ACCESS aims to supplement notification data by
gaining a better understanding of chlamydia testing and
positivity rates within a range of health service networks.
The methods of the ACCESS systems have been de-
scribed in detail elsewhere [13,14]. ACCESS includes five
clinical networks made up of SHSs, family planning clinics,
GP clinics, antenatal clinics and ACCHSs; and a laboratory
network to collectively monitor the uptake and outcome of
chlamydia testing in Australia using patient encounter
data. ACCESS is managed by a coordinating committee
and each of the six networks is overseen by a steering com-
mittee which manages all aspects of the project includingdevelopment, implementation, interpretation and analysis
of data from individual networks.
Data inclusion
We included all consultation and routine chlamydia testing
data from 25 GP clinics, 22 SHSs and six ACCHSs within
ACCESS for both Aboriginal and non-Indigenous patients.
These services nominated to participate in the ACCESS
study, and were selected based on their size and geograph-
ical location to ensure national representatives [13]. A
Memorandum of Understanding between research agen-
cies and the National Aboriginal Community Controlled
Health Organisation (NACCHO) supported ACCHSs
involvement.
Data from GP clinics and ACCHSs were collected using
software called GRHANITE developed by the Rural Clin-
ical School at University of Melbourne [14]. GRHANITE
collected client demographic, health service utilisation
and testing and positivity data from each service’s elec-
tronic medical records. Data from the SHSs were directly
extracted from their respective patient management sys-
tems. All extracted data was de-identified at the clinical
service before sharing.Data analysis
Data on patient demographics, chlamydia testing and
positivity were analysed for patients aged 16–29 years,
who attended the services in 2009. We calculated: (i) the
number of patients who were identified or identified as
Aboriginal for each network; (ii) the proportion of patients
tested at least once for chlamydia (testing rate) (iii) the
proportion of those tested who had a positive test result
(chlamydia positivity) where the result was known. All re-
sults were stratified by Aboriginal status, sex, age groups
and clinic networks.Ethics
Ethical approval for the ACCHS network was gained
from six Human Research Ethics Committees located at
the Alfred Hospital, (Victoria); Aboriginal Health and
Medical Research Council (New South Wales); Aboriginal
Health Research Ethics Committee (South Australia);
Central Australian Human Research Ethics Committee
Northern Territory (NT)]; Western Australian (WA) Abo-
riginal Health Information and Ethics Committee; and the
Human Research Ethics Committee of the NT Depart-
ment of Health and Families and Menzies School of
Health Research (NT). Approval for the GP network was
granted by the Royal Australian College of General Practi-
tioners (RACGP). Approval for the SHS network was
granted by the Human Research Ethics Committees
(HRECs) of St Vincent’s Hospital and the University of
New South Wales with further ethical approval granted by
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ing SHSs.Results
Health services
Of the six ACCHS one was located in a metropolitan area
and the remaining were in regional/remote areas, whereas
the majority of the GP clinics (14 of 25; 56%) and SHSs
(13 of 22; 59%) were located in metropolitan areas.Patient demographics
Within ACCHSs 4,950 unique patients aged 16–29 years
attended during 2009. Of these, 60% were female, 33%
were aged 16–19 years and 37% were aged 20–24 years. In
the 25 GP clinics, 34,462 unique patients aged 16–29
years attended during 2009; 61% were female, 26% were
aged 16–19 years and 38% aged 20–24 years. In the same
year, 20,691 16–29 year olds attended the 22 SHSs, of
these 48.9% were female; 17% were aged 16–19 years and
44% were aged 20–24 years (Table 1).Aboriginal status
The majority of patients (85%) attending ACCHSs were
identified as Aboriginal, 11% as non-Indigenous, and in
4% this status was not recorded. Of all patients attending
GP clinics, 1.3% were recorded as being Aboriginal, 31.2%
as non-Indigenous, and for 67.5% of patients Aboriginal
status was not recorded. Aboriginal patients comprised,
4.1% of the total patients seen at SHSs, with 91.5% re-
corded as non-Indigenous and for 4.3% Aboriginal status
was not recorded (Table 1).Chlamydia testing rates
Chlamydia testing rates in each of the networks among
Aboriginal patients were: 19.8% (95% CI:18.6%-21.0%) at-
tending ACCHSs; 4.3% (95% CI:2.6-6.6%) at GP clinics,
and 75.5% (95% CI:72.5%-78.4%) at SHSs (p < 0.01)
(Table 2). Whereas, in non-Indigenous people, the testing
rates were: 8.6% (95% CI:8.0%-9.1%) at ACCHSs, 11.2%
(95% CI:8.6%-14.1%) at GP clinics, and 78.3% (95%
CI:77.7%-78.9%) at SHSs (p < 0.01). Testing rates were
higher in both Aboriginal and non-Indigenous males
attending SHSs, 81.7% vs. 79.9% respectively; compared to
71.5% of females (both Aboriginal and non-Indigenous)
(p < 0.01 for both). Conversely testing rates were higher
for females both Aboriginal and non-Indigenous at
ACCHS compared to males (22.5% vs 15.6%, p < 0.01 and
13.7% vs. 7.6%, respectively (p < 0.05 for both). Testing
rates were similar between Aboriginal and non-Indigenous
patients, both males and females at GP clinics (5.2% vs
2.1%; p = 0.136).Chlamydia positivity rates
Among Aboriginal patients, chlamydia positivity at ACC
HSs was 8.6% (95% CI:6.8%-10.8%) (72 of 833 patients
tested), 15.8% (95% CI:3.4%-39.6%) (3/19) at GP clinics,
and 22.7% (95% CI:19.5%-26.2%) (145/638) at SHSs (p <
0.01). Among non-Indigenous people, chlamydia positivity
at ACCHS was 11.3% (95% CI:4.7%-22.0%) (7/62), 8.2%
(95% CI:6.4%-10.1%) (75/920) at GP clinics, and 12.7%
(95% CI:12.2%-13.2%) (1887/14851) at SHSs (p < 0.01)
(Table 2).
Among Aboriginal females, chlamydia positivity was
highest at SHSs; 21.5% (95% CI:17.3%-26.1%), while those
tested at ACCHSs had a positivity rate of 9.4% (95%
CI:7.2%-12.1%,p < 0.01). Among Aboriginal males chla-
mydia positivity rates within SHSs was 24.5% (95%
CI:19.5%-30.0%) and within ACCHSs 8.1% (95% CI:4.8%-
12.5%,p < 0.01) (Table 2).
Discussion
This report adds significantly to our understanding of the
health care utilisation by young Aboriginal people and
complements STI notification data by informing chla-
mydia positivity across a range of primary care services-
two generalist (GP and ACCHSs) and one specialised
(SHSs). The study is the first comprehensive analyses, and
certainly the biggest that compares Aboriginal/non-Abori-
ginal populations using the same recruitment methods for
both populations. Previous comparisons have been based
virtually entirely on notification data, which is subject to
variabililty due to dependence on testing uptake.
Data from three different types of primary care services
are represented, covering a period of 12 months with over
60,100 patients. Elsewhere, we reported the representa-
tiveness of participating sites according to Australian
population distributions [13]. Accordingly, results particu-
larly related to Chlamydia testing and positivity are likely
to be generalisable to the Australian population aged 16–
29 years.
At the participating services, 4.1% of clients at SHSs
were identified as Aboriginal, compared to 1.3% at GP
clinics and 85% at ACCHSs. Aboriginal attendances in
GPs and ACCHSs from this dataset were consistent with
those reported in national audits across all ages, and af-
firm that young Aboriginal people only make up a small
proportion of those attending mainstream encounters the
patient identified as sexual health services for STI care
and management. Of all patients attending GP clinics in
2011–2012 1.5% were identified as Aboriginal [15] while
78% of patients who attended ACCHS in 2010–2011 were
identified as Aboriginal [16]. Given that young Aboriginal
people make up 4% of Australia’s total 15–29 year old
population [17], further efforts are required to make GP
services more accessible to them. It should be noted how-
ever that young men accessed SHSs more than the GP
Table 1 Aboriginal status recording, by ACCESS network, age group, sex and area of residence, among 16–29 year olds
General practice clinics(a) Sexual health services(b) Aboriginal community controlled health
services(c)
Patients Aboriginal Non-
indigenous
Not
recorded
Patients Aboriginal Non-
indigenous
Not
recorded
Patients Aboriginal Non-
indigenous
Not
recorded
n n (%) n (%) n (%) n n (%) n (%) n (%) n n (%) n (%) n (%)
Males Age group
(years)
16-19 3,604 50 (1.4) 1,164 (32.3) 2,390 (66.3) 1379 148 (10.7) 1202 (87.2) 29 (2.1) 657 582 (88.6) 58 (8.8) 17 (2.6)
20-24 4,920 53 (1.1) 1,461 (29.7) 3,406 (69.2) 4716 128 (2.7) 4404 (93.4) 184 (3.9) 683 575 (84.2) 77 (11.3) 31 (4.5)
25-29 4,751 37 (0.8) 1,469 (30.9) 3,245 (68.2) 4484 58 (1.3) 4219 (94.1) 207 (4.6) 624 512 (82.1) 76 (12.2) 36 (5.8)
Area of
residence
Metro 7,850 113 (1.4) 2,261 (28.8) 5,475 (69.7) 6990 78 (1.1) 6612 (94.6) 300 (4.3) 403 332 (82.4) 63 (15.6) 8 (2.0)
Regional/
remote
5,324 27 (0.5) 1,813 (34.0) 3,485 (65.5) 2669 231 (8.6) 2377 (89.1) 61 (2.3) 1528 1318 (86.3) 136 (8.9) 74 (4.8)
Female Age group
(years)
16-19 5,410 98 (1.8) 1,822 (33.7) 3,490 (64.5) 2233 266 (11.9) 1910 (85.5) 57 (2.6) 962 844 (87.7) 89 (9.3) 29 (3.0)
20-24 8,059 112 (1.4) 2,510 (31.1) 5,437 (67.5) 4380 140 (3.2) 4028 (92.0) 212 (4.8) 1,126 940 (83.5) 140 (12.4) 46 (4.1)
25-29 7,718 97 (1.3) 2,333 (30.2) 5,288 (68.5) 3499 102 (2.9) 3165 (90.5) 232 (6.6) 898 754 (84.0) 116 (12.9) 28 (3.1)
Area of
residence
Metro 12,051 228 (1.9) 3,337 (27.7) 8,486 (70.4) 6076 93 (1.5) 5633 (92.7) 350 (5.8) 571 492 (86.2) 74 (13.0) 5 (0.9)
Regional/
remote
8,970 74 (0.8) 3,295 (36.7) 5,601 (62.4) 3141 363 (11.6) 2699 (85.9) 79 (2.5) 2380 2023 (85.0) 261 (11.0) 96 (4.0)
(a)based on 25 clinics.
(b)based on 22 clinics.
(c)based on 6 clinics.
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Table 2 Chlamydia testing and positivity rate, by Aboriginal status, ACCESS network, age group, sex and area of
residence, among 16–29 year olds
Aboriginal Category Breakdown General practice
clinics (a)
Sexual health
services (b)
Aboriginal community
controlled health
services (c)
Patients Tested Positive* Patients Tested Positive Patients Tested Positive*
N n (%) n (%) n n (%) n (%) n n (%) n (%)
Aboriginal and/
or Torres Strait
Islander
All 447 19 (4.3) 3 (15.8) 845 638 (75.5) 145 (22.7) 4207 833 (19.8) 72 (8.6)
Sex Male 140 3 (2.1) 1 (33.3) 334 273 (81.7) 67 (24.5) 1669 261 (15.6) 18 (8.1)
Female 307 16 (5.2) 2 (13.3) 508 363 (71.5) 78 (21.5) 2538 572 (22.5) 54 (9.4)
Age
group
(years)
16-19 148 7 (4.7) 2 (28.6) 415 321 (77.3) 76 (23.7) 1426 268 (18.8) 27 (10.1)
20-24 165 7 (4.2) 1 (14.3) 269 208 (77.3) 52 (25.0) 1515 308 (20.3) 29 (9.4)
25-29 134 5 (3.7) -(0.0) 161 109 (67.7) 17 (15.6) 1266 257 (20.3) 16 (6.2)
Patient
area of
residence
Metropolitan 341 8 (2.3) -(0.0) 172 115 (66.9) 17 (14.8) 824 171 (20.8) 14 (8.2)
Regional/
remote
101 11 (10.9) 3 (27.3) 596 468 (78.5) 119 (25.4) 3341 659 (19.7) 57 (8.6)
Non-Indigenous All 10,759 920 (8.6) 75 (8.2) 18,968 14851
(78.3)
1887 (12.7) 556 62 (11.2) 7 (11.3)
Sex Male 4,094 218 (5.3) 22 (10.1) 9,825 7848 (79.9) 1051 (13.4) 211 16 (7.6) 2 (12.5)
Female 6,665 702 (10.5) 53 (7.5) 9,103 6979 (76.7) 833 (11.9) 345 46 (13.3) 5 (10.9)
Age
group
(years)
16-19 2,986 238 (8.0) 25 (10.5) 3,116 2414 (77.5) 373 (15.5) 147 12 (8.2) 2 (16.7)
20-24 3,971 409 (10.3) 42 (10.4) 8,444 6693 (79.3) 915 (13.7) 217 29 (13.2) 4 (13.8)
25-29 3,802 273 (7.2) 8 (2.9) 7,408 5744 (77.5) 599 (10.4) 192 21 (10.9) 1 (4.8)
Patient
area of
residence
Metropolitan 5,598 448 (8.0) 28 (6.3) 12,207 9580 (78.0) 1124 (11.7) 137 8 (5.8) 2 (25.0)
Regional/
remote
5,108 470 (9.2) 47 (10.0) 5,082 3899 (76.7) 587 (15.1) 397 53 (13.4) 5 (9.4)
a) based on 25 clinics b) based on 22 clinics c) based on 6 clinics.
*Positivity rates based only on individuals tested for whom a result was available.
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they are accessing clinics on their own or (ii) they attend
as named contacts. Whatever the case, all services should
be encouraged to promote their services to young men.
The Aboriginal status of patients was better recorded at
ACCHSs and SHSs compared with GP clinics where only
one third of patients status was recorded. Improving data
quality on Aboriginal status within GP clinics is a priority
of Australian Governments [18] with the Close the Gap
Indigenous health incentive payment aiming to improve
recording of Aboriginal status [19].
This study confirms that the majority of ACCHSs pa-
tients are Aboriginal people and that people aged 16–29
years attend these services for health care, including for
STI screening. This concurs with two previous studies,
the first, a cross sectional survey of young people aged
16–29 years where 54% reported that they had an STI
test in the previous year and did so at an ACCHS [20],
and a second study of resilience related to STI and blood
borne viruses whereby young people reported positive as-
pects of attending an ACCHS for STI and BBV screening
and management. In the latter study, young Aboriginal
people described the comfort and understanding they
experienced at the ACCHS; and positive personal relationships especially with Indigenous care providers [21].
Our results support the central role that ACCHSs play in
STI service provision for Aboriginal people.
Further efforts are required to improve STI testing rates
in primary care. Testing rates among Aboriginal patients
attending ACCHSs and GP clinics were quite different
with testing rates within ACCHS almost five times greater
than that offered by GPs for both Aboriginal and non-
Indigenous patients. As expected, testing rates were high
among both Aboriginal and non-Indigenous patients
attending SHSs. There are two main reasons to test for
Chlamydia- to screen those who are asymptomatic or to
diagnose symptomatic infection. Thus, chlamydia testing
rates of services may reflect their adherence to screening
protocols, as well as the burden of disease affecting their
populations. With regards to screening, clinical practice
guidelines recommend that all sexually active people up to
the age of 29 years be offered a chlamydia test at least an-
nually [22,23]. The lower rates of testing within GPs and
ACCHSs compared with SHSs could be due to a number
of factors: patients declining testing; patients not being
offered testing (staff lacking awareness of screening guide-
lines, due lack of time and awareness about chlamydia
testing amongst clinic staff, or sensitivities regarding
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order to achieve higher chlamydia testing rates in GP and
ACCHS settings, supportive quality improvement strat-
egies are warranted [27,28] as well as initiatives such as
offering a test to all patients prior to the consultation [29]
Quality improvement audits are a key feature of the Clos-
ing the Gap funding initiatives particularly involving
ACCHSs [30] but do not currently explore STI testing
patterns.
Mathematical modelling has suggested that increasing
rates of chlamydia testing to 40% in males and females
aged less than 25 years or to 20% in young people aged
less than 30 years could halve the prevalence of chlamydia
within ten years; with most of this decline occurring
within the first four years [31]. If the intent is to achieve
high chlamydia testing rates in the population, health pro-
motion and clinical education and systems within ACCHS
and GPs should address the different health care utilisa-
tion patterns of Aboriginal females and males; since in
most ACCESS sites a higher proportion of females either
attended or were tested than males.
A key strength of this study is that the results reflect
actual clinical practice in the participating health services.
All data were collected retrospectively and thus did not
influence the decision to offer a chlamydia test or not. In
addition, within each network, study data were collected
from services that are geographically dispersed across the
country; thus reducing biases introduced when data are
reported from one service or region.
A limitation of the study was the poor identification of
Aboriginal patients at mainstream GP clinics with more
than two thirds of patients having an unknown Aboriginal
status. The poor completeness of Aboriginal status in GP
clinics means we cannot be confident about the true test-
ing and positivity rates in Aboriginal patients. In addition,
the study did not record patients who declined to have a
test when offered one. Clinical audits would be needed to
measure the extent of decline in any of these primary care
facilities. Further, we were not able to identify symptom-
atic patients from asymptomatic patients making inter-
pretation of positivity results difficult to correlate with
community prevalence rates. Only first patient visits in-
volving Chlamydia testing were counted, thus excluding
subsequent testing and positivity data. Finally, in view of
the small sample size of GP clinics and ACCHSs in the
ACCESS network, these findings may not be representa-
tive of all such health services because of the small sample
size of these clinics in Australia.
Conclusions
In conclusion, this study provides a snapshot of chlamydia
testing and positivity among young people attending three
types of primary care health services. Improved complete-
ness of recording of Aboriginal status should be a priorityin GP clinics, not only to evaluate chlamydia testing and
prevention programs but also for other Closing the Gap
initiatives that are directed at mainstream general practice
[32]. Quality improvement initiatives will play a key role
in influencing adherence to clinical practice guideline
recommendations for chlamydia testing and are becoming
a feature of current funding programs. More research is
needed to determine how effective mainstream strategies
are at engaging young Aboriginal people to the range of
health services available to them.
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